Skip to main content

Table 3 Baseline characteristics (mean, standard deviation)

From: A feasibility randomised controlled trial of a Fibromyalgia Self-management Programme for adults in a community setting with a nested qualitative study (FALCON)

 

Control

(n = 34)

Intervention

(n = 32)

Age (years), mean (SD)

53.18 ± 14.88

51.16 ± 14.71

Female (n, %)

31 (91.2)

28 (87.5)

Male (n, %)

3 (8.8)

4 (12.5)

FIQR

61.63 ± 17.45 a

62.46 ± 20.92

ASES-8

3.74 ± 1.57 b

3.83 ± 1.58

CFS

24.43 ± 6.00

22.76 ± 6.32

SF36 PF

30.00 ± 21.46

37.07 ± 27.96

SF36 RP

2.21 ± 7.20

5.47 ± 13.82

SF36 RE

24.51 ± 36.98

31.25 ± 35.86

SF36 VIT

21.96 ± 17.71

22.86 ± 17.64

SF36 MH

52.12 ± 15.21

54.50 ± 17.65

SF36 SF

38.97 ± 20.36

39.84 ± 27.94

SF36 BP

26.91 ± 17.02

22.58 ± 14.90

SF36 GH

23.27 ± 16.80

33.13 ± 16.64

EQ-5D-5L Health

45.82 ± 21.03

45.38 ± 19.81

EQ-5D-5L Index

0.33 ± 0.30

0.36 ± 0.29

JSS

13.50 ± 4.23

13.10 ± 4.07 c

  1. Revised Fibromyalgia Impact Questionnaire (FIQR), Arthritis Self-Efficacy Scale-8 (ASES-8), Chalder Fatigue Scale (CFS), Short Form 36 Physical Function (SF36 PF), Short Form 36 Role Physical (SF36 RP), Short Form 36 Role Emotional (SF36 RE), Short Form 36 General Health (SF36 GH), Short Form 36 Bodily Pain (SF36 BP), Short Form 36 Vitality (SF36 VIT), Short Form 36 Mental Health (SF36 MH), Short Form 36 Social Functioning (SF36 SF), 5-level EQ-5D version (EQ5DL), Index Jenkins Sleep Scale (JSS)
  2. a The number of complete FIQR outcome measures included in the analysis (Control n = 32)
  3. b The number of complete ASES-8 outcome measures included in the analysis (Control n = 33)
  4. c The number of complete JSS outcome measures included in the analysis JSS (Intervention n = 31)
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us